These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9350394)

  • 61. Is a central action of acute antimigraine drugs essential?
    Goadsby PJ
    Cephalalgia; 1997 Jun; 17 Suppl 17():10-1. PubMed ID: 9218879
    [No Abstract]   [Full Text] [Related]  

  • 62. Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?
    Dahlöf CG; Mathew N
    Cephalalgia; 1998 Oct; 18(8):539-45. PubMed ID: 9827245
    [No Abstract]   [Full Text] [Related]  

  • 63. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
    Goldstein D
    Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
    [No Abstract]   [Full Text] [Related]  

  • 64. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
    Rolan P
    Cephalalgia; 1997 Oct; 17 Suppl 18():21-7. PubMed ID: 9399014
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs.
    Carel I; Ghaleh B; Edouard A; Dubois-Rande JL; Parsons AA; Giudicelli JF; Berdeaux A
    Br J Pharmacol; 2001 Mar; 132(5):1071-83. PubMed ID: 11226138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
    Bartleson JD
    Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
    [No Abstract]   [Full Text] [Related]  

  • 67. Sumatriptan and zolmitriptan.
    Nurs Times; 2005 Sep 27-Oct 3; 101(39):31. PubMed ID: 16218117
    [No Abstract]   [Full Text] [Related]  

  • 68. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ; Charlesworth BR
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CNS effects of sumatriptan and rizatriptan.
    Silberstein SD; Diener HC; McCarroll KA; Lines CR
    Cephalalgia; 2004 Jan; 24(1):78; author reply 78-9. PubMed ID: 14687019
    [No Abstract]   [Full Text] [Related]  

  • 70. Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application.
    Srinivas NR; Syed M
    J Pain Palliat Care Pharmacother; 2016; 30(1):13-24. PubMed ID: 26865407
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Side effects of triptans].
    Igarashi H
    No To Shinkei; 2004 Sep; 56(9):754-9. PubMed ID: 15552864
    [No Abstract]   [Full Text] [Related]  

  • 72. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
    Yu XJ; Waeber C; Castanon N; Scearce K; Hen R; Macor JE; Chauveau J; Moskowitz MA
    Mol Pharmacol; 1996 May; 49(5):761-5. PubMed ID: 8622623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastric motor effects of triptans: open questions and future perspectives.
    Cipolla G; Sacco S; Crema F; Moro E; De Ponti F; Frigo G
    Pharmacol Res; 2001 Mar; 43(3):205-10. PubMed ID: 11401410
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.
    Dixon RM; Meire HB; Evans DH; Watt H; On N; Posner J; Rolan PE
    Cephalalgia; 1997 Oct; 17(6):639-46. PubMed ID: 9350383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The 5-HT7 receptor: orphan found.
    Eglen RM; Jasper JR; Chang DJ; Martin GR
    Trends Pharmacol Sci; 1997 Apr; 18(4):104-7. PubMed ID: 9149537
    [No Abstract]   [Full Text] [Related]  

  • 76. 5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist.
    Glennon RA; Hong SS; Dukat M; Teitler M; Davis K
    J Med Chem; 1994 Sep; 37(18):2828-30. PubMed ID: 8071931
    [No Abstract]   [Full Text] [Related]  

  • 77. Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.
    Longmore J; Shaw D; Smith D; Hopkins R; McAllister G; Pickard JD; Sirinathsinghji DJ; Butler AJ; Hill RG
    Cephalalgia; 1997 Dec; 17(8):833-42. PubMed ID: 9453271
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Presynaptic receptors: more hetero than auto.
    Laduron PM
    Trends Pharmacol Sci; 1998 Apr; 19(4):127-30. PubMed ID: 9612086
    [No Abstract]   [Full Text] [Related]  

  • 79. [Zolmitriptan-induced hepatotoxicity].
    Redondo Cerezo E; Espinosa Aguilar MD; Nogueras López F; Martín-Vivaldi Martínez R
    Gastroenterol Hepatol; 2003 Dec; 26(10):664. PubMed ID: 14670242
    [No Abstract]   [Full Text] [Related]  

  • 80. Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan.
    Hood S; Birnie D; Murray LS; MacIntyre PD; Hillis WS
    Br J Clin Pharmacol; 1999 Sep; 48(3):331-5. PubMed ID: 10510143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.